Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives Average Recommendation of “Moderate Buy” from Brokerages

Merit Medical Systems, Inc. (NASDAQ:MMSI) has earned an average rating of “Moderate Buy” from the eleven ratings firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $92.80.

MMSI has been the subject of several recent analyst reports. Barrington Research reduced their target price on shares of Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research note on Monday, April 20th. Canaccord Genuity Group dropped their price target on shares of Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Needham & Company LLC cut their price target on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a report on Friday, May 1st. JPMorgan Chase & Co. reduced their price objective on shares of Merit Medical Systems from $95.00 to $77.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, BTIG Research started coverage on shares of Merit Medical Systems in a research note on Friday, February 6th. They issued a “buy” rating and a $107.00 price objective for the company.

Insider Activity at Merit Medical Systems

In other Merit Medical Systems news, Director Lynne N. Ward sold 5,000 shares of the business’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $62.61, for a total value of $313,050.00. Following the transaction, the director owned 7,809 shares of the company’s stock, valued at approximately $488,921.49. The trade was a 39.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian G. Lloyd acquired 2,000 shares of Merit Medical Systems stock in a transaction on Thursday, May 7th. The stock was acquired at an average price of $62.62 per share, with a total value of $125,240.00. Following the purchase, the insider directly owned 2,000 shares in the company, valued at approximately $125,240. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Merit Medical Systems

A number of hedge funds have recently made changes to their positions in the business. Los Angeles Capital Management LLC purchased a new position in shares of Merit Medical Systems in the 4th quarter worth about $25,000. Maseco LLP purchased a new stake in Merit Medical Systems during the fourth quarter worth about $26,000. Torren Management LLC bought a new stake in Merit Medical Systems in the fourth quarter worth about $38,000. Covestor Ltd raised its position in Merit Medical Systems by 252.6% in the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 336 shares during the period. Finally, Danske Bank A S purchased a new position in Merit Medical Systems in the third quarter valued at about $42,000. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Stock Up 0.0%

MMSI stock opened at $63.09 on Monday. The firm has a market capitalization of $3.76 billion, a PE ratio of 27.31, a P/E/G ratio of 1.96 and a beta of 0.54. The company has a quick ratio of 3.46, a current ratio of 5.08 and a debt-to-equity ratio of 0.45. Merit Medical Systems has a twelve month low of $59.74 and a twelve month high of $96.74. The stock’s 50 day moving average is $66.31 and its 200-day moving average is $76.87.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.10. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The business had revenue of $381.88 million during the quarter, compared to the consensus estimate of $377.59 million. During the same quarter in the prior year, the company posted $0.86 earnings per share. Merit Medical Systems’s revenue was up 7.4% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Sell-side analysts expect that Merit Medical Systems will post 3.62 EPS for the current fiscal year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.